📰 *FDA Nearing Decision Whether to Authorize Second Round of Omicron-Targeting Covid-19 Boosters, Sources Say — WSJ Could Come Within a Few Weeks, Sources Say Booster Authorization Would Be for Elderly, Immunocompromised, Sources Say $PFE $BNTX $MRNA $MRK $JNJ

*FDA Nearing Decision Whether to Authorize Second Round of Omicron-Targeting Covid-19 Boosters, Sources Say — WSJ

Could Come Within a Few Weeks, Sources Say

Booster Authorization Would Be for Elderly, Immunocompromised, Sources Say $PFE $BNTX $MRNA $MRK $JNJ